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Abstract
Legumes have the unique ability to host nitrogen-fixing Rhizobium bacteria as symbiosomes inside root nodule cells. To get
insight into this key process, which forms the heart of the endosymbiosis, we isolated specific cells/tissues at different
stages of symbiosome formation from nodules of the model legume Medicago truncatula using laser-capture
microdissection. Next, we determined their associated expression profiles using Affymetrix Medicago GeneChips. Cells
were collected from the nodule infection zone divided into a distal (where symbiosome formation and division occur) and
proximal region (where symbiosomes are mainly differentiating), as well as infected cells from the fixation zone containing
mature nitrogen fixing symbiosomes. As non-infected cells/tissue we included nodule meristem cells and uninfected cells
from the fixation zone. Here, we present a comprehensive gene expression map of an indeterminate Medicago nodule and
selected genes that show specific enriched expression in the different cells or tissues. Validation of the obtained expression
profiles, by comparison to published gene expression profiles and experimental verification, indicates that the data can be
used as digital ‘‘in situ’’. This digital ‘‘in situ’’ offers a genome-wide insight into genes specifically associated with subsequent
stages of symbiosome and nodule cell development, and can serve to guide future functional studies.
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Introduction
Legume plants have the unique ability to host nitrogen-fixing
bacteria, collectively called rhizobia, in a newly formed organ, the
so-called root nodule. Inside specialized cells of the nodule, the
rhizobium bacteria are accommodated as novel organelle-like
structures called symbiosomes [1]. Symbiosomes fix atmospheric
nitrogen into ammonium which is transferred to the plant in
return for carbohydrates [2]. This symbiosis is one of the most
important sources of biologically fixed nitrogen and allows
legumes to grow in nitrogen poor soil conditions, without the
need of chemical fertilizer. To better understand this ecologically
and agriculturally important interaction a key goal is the
identification of the transcriptome changes that are associated
with the different stages of the interaction and to link gene
expression to the corresponding developmental processes. One of
the key processes that occurs in the nodule, and is at the heart of
the symbiosis, is the accommodation and development of the
bacteria into nitrogen-fixing symbiosomes. Here, we aim to
characterize the transcriptome of specific cells/tissues inside the
nodule at different stages of symbiosome formation in the model
legume Medicago truncatula (Medicago). The developmentally
structured organization of Medicago nodules makes them an ideal
system to study the different stages of nodule and symbiosome
development.
Nodule development is triggered by rhizobial lipochito-oligo-
saccharide signal molecules, called Nod factors that activate a
signaling cascade which triggers transcriptional responses that
control nodule organogenesis as well as rhizobial infection and
symbiosome formation [3]. Rhizobia enter the root and develop-
ing nodule through tubular structures called infection threads.
Typically, these infection threads originate in root hairs that curl
around attached bacteria after which they traverse the cortex to
deliver the bacteria to the developing primordium [4]. When the
infection threads reach the cells of the nodule primordium, the
bacteria are released from the cell wall bound infection threads
and are taken up into the cells through an endocytosis-like process
by which they become surrounded by a specialized plant
membrane and organelle-like symbiosomes are formed [5]. After
the infection threads invade the nodule primordium, an apical
meristem is established that continues to add cells to the
developing nodule [6]. In Medicago, this meristem stays active
by which an elongated indeteminate nodule is formed. These
nodules show a strictly organized zonation, where infection thread
formation followed by symbiosome formation and subsequent
development occur along a developmental gradient [7].
Zone I of the nodule consists of the apical nodule meristem,
consisting of uninfected dividing cells. In Zone II, the infection
zone, plant and bacterial cell differentiation occur and this zone
can be further divided into a distal and proximal region [7]. In the
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distal infection zone, ,4 cell layers just below the meristem,
infection threads invade the cells coming from the meristem. Here
so-called unwalled infection droplets extrude from the cell wall
bound infection threads from where the bacteria are individually
pinched off into the cytoplasm by which they become surrounded
by the plant-derived symbiosome membrane [8,9]. Next, the
bacteria (now called bacteroids) divide and start filling the cells. In
Medicago, bacteroid and symbiosome membrane division are
strictly coupled by which symbiosomes remain single bacteria-
containing compartments. In the proximal ,4 cell layers of the
infection zone, the bacterioids lose their ability to divide and start
elongating. This terminal differentiation process has been corre-
lated with endoreduplication and cell enlargement occurring in
both the host cell as well as the bacteria and involves a family of
nodule-specific cysteine-rich NCR peptides [10,11]. In this way
the individual symbiosomes become .10x bigger and almost
completely fill the host cells. In Zone III, the fixation zone, the
bacteria are fully differentiated into their nitrogen fixing form and
nitrogen fixation takes place, which is facilitated by the micro-
aerobic conditions in the infected nodules cells and correlates with
the induction of bacterial nitrogen fixation genes [12,13]. Some
cells originating from the meristem never become infected by the
bacteria and these can be clearly seen as relatively small uninfected
cells in between the large infected cells. These uninfected cells are
thought to play an essential role in metabolite transport to and
from the infected cells [14]. Eventually, as the nodule ages (,3–4
weeks post-inoculation), the symbiosis starts to break down and
senescence of both symbiosomes and host cells occurs in Zone IV
(senescent zone) [15]. The different zones mentioned above,
except for the meristem, are surrounded at the periphery by the
nodule parenchyma (nodule inner cortex), vascular bundles and
the nodule endodermis. Further, the entire nodule is surrounded
by an outer cortex [7].
In the past years, various expression profiling strategies have
been used during both early and late stages of nodulation to
identify the genes that are associated with different stages of the
interaction [16–25]. Such studies either focused on identifying
transcriptome changes within hours of treatment with symbiotic
signals, with Rhizobium inoculation, or compared whole nodules
at different time points after inoculation. To establish a link
between gene expression and processes in the nodule, such as
meristem formation, symbiosome formation, differentiation or
maintenance, two recent studies combined transcriptome analyses
of wild-type Medicago nodules with that of nodules impaired in
their development due to bacterial and plant mutations [26,27].
This revealed several expression profiles that correlated with
distinct developmental programs in the nodule. However, this
approach does not clearly distinguish between different cell types
in the nodule. Furthermore, the use of plant and bacterial mutants
has the inherent risk that genes are affected that are not normally
expressed at corresponding developmental stages in wild-type
nodules. Furthermore, genes that are differentially expressed in a
specific cell type or at a specific stage might not be detected in
whole nodule samples due to dilution effects by other more
abundant cells.
Here, we used laser-capture microdissection (LCM) to isolate
specific nodule cells at different stages of symbiosome develop-
ment. To this end, we collected cells from the infection zone,
divided into a distal region (where symbiosome formation and
division occur) and a proximal region (where symbiosomes are
mainly differentiating), as well as infected cells from the fixation
zone containing mature nitrogen fixing symbiosomes. To include
uninfected reference/control tissues, we also collected cells from
the meristem as well as uninfected cells from the fixation zone.
The captured cells/tissues were used to determine their associated
expression profiles using Affymetrix Medicago GeneChips [22].
The resulting digital ‘‘in situ’’ offers a valuable data set to identify
novel genes controlling nodule development and to unravel the
unique ability of legumes to host the bacteria as nitrogen fixing
organelles, which forms the heart of the Rhizobium-legume
symbiosis, at a molecular level.
Results and Discussion
Laser Capture Microdissection of Medicago Nodules
To isolate distinct nodule cells at different stages of symbiosome
development we used LCM, which allows the rapid and specific
isolation of cells/tissues based on conventional histological
identification [28]. To preserve as best as possible the zonation
and histological detail, three week old nodules were fixed with
Farmer’s fixative and embedded in paraffin (according to [29]).
Three week old Medicago nodules typically contain an active
meristem at the apex, a well-defined infection zone and an active
fixation zone. The quality of the RNA in the paraffin embedded
tissues was checked before and after fixation and sectioning.
Approximately 300 ng high quality total RNA could be isolated
from a single paraffin embedded nodule (data not shown).
Subsequently, 8 micrometer thick median longitudinal sections
were used to isolate cells from the meristem, ,4 cell layers of the
distal infection zone (DIZ), ,4 cell layers from the proximal
infection zone (PIZ), infected (IC), and uninfected (UIC) cells from
the fixation zone (Fig. 1a–o). Only those sections were used that
showed a well-defined zonation and where histological preserva-
tion was sufficient to allow the identification of the different cell
types. However, as the exact borders between the meristematic
cells and the cells of the distal infection zone and between the
distal and proximal infection zones are difficult to distinguish
precisely by light microscopy, it is possible that some overlap exists
between these laser-captured tissues. The same holds for the
uninfected cells, which are relatively small, highly vacuolated and
have irregular shapes in between the large infected cells. For each
tissue/cell-type 3 biological replicates (e.g. different nodules) each
consisting of ,50 cells pooled from 8 consecutive sections were
collected and used for RNA isolation.
Cell-type Specific Expression Profiling of Medicago Root
Nodules
To determine the transcriptome of the isolated cell/tissue types
we used the Affymetrix Medicago GeneChips, which contains
50900 Medicago probe sets representing the majority of genes in
this species [22]. The RNA isolated from the LCM cells was
amplified using a two-step RNA amplification protocol to obtain
sufficient material for hybridization experiments (see methods).
Analyses of the expression levels of control genes (i.e. GAPDH),
divided into 39- and 59-regions, showed that there is a bias towards
the 39-end of transcripts (data not shown). This can be due to the
two-step T7 amplification protocol and/or due to degradation of
RNA in the LCM samples. Each gene on the Medicago GeneChip
is represented by 11 probes. To account for this 39-bias we re-
analyzed the data using only the five most 39 located probe sets
instead of all 11 probe sets. Expression data are available at the
Gene Expression Omnibus (GEO accession GSE43354). Although
most probe sets on the Medicago array are designed in the 39part
of transcripts, the observed 39-bias may affect the reliable detection
of genes for which the probe sets on the array are located in more
59 regions [30].
To identify genes specifically correlated with the developmental
processes in the different cell/tissue types we first selected genes
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that show enriched expression, at least 2-fold higher (q ,0,1
(p,0.01)), compared to (the average of) all other LCM samples in:
1) the meristem (M), 2) the distal infection zone (DIZ), 3) the
proximal infection zone (PIZ), 4) the complete infection zone (DIZ
and PIZ), 5) infected cells (IC) of the fixation zone, and 6)
uninfected cells (UIC). This data set is represented as Table S1.
Figure 2 summarizes the number of genes that show at least 2 fold
enriched expression compared to the average of the other LCM
samples.
From this analysis, we next selected those genes that show at
least a 2 fold higher enrichment factor in an individual/specific
cell-type compared to any of the other cell types (Tables S2, S3,
S4, S5, S6, S7). These genes will be referred to as ‘‘cell-type
enriched’’ genes and are summarized in Table 1. In total 4999
genes show at least 2-fold enriched expression in a specific nodule
tissue/cell type.
Validation of Cell-type Specific Expression in Medicago
Root Nodules
To validate the ‘‘specificity’’ of the obtained digital expression
profiles and to establish to what extent the array data can be used
as digital ‘‘in situ’’ we first compared the LCM microarray data to
published expression profiles from promoter-reporter analyses or
in situ hybridizations (summarized in Table 2). Additionally, we
analyzed the expression profile of several selected genes in the
nodule (Table 2).
Meristem vs infection zone. First, we compared the
meristem to the infection zone and surrounding cortex. The
absence of MtN13 (Mtr.33137.1.S1_at; Mtr.37852.1.S1_at) gene
expression from the ‘‘meristem-enriched’’ data set, which is known
to be highly expressed specifically in the nodule cortex [31],
indicates that the meristem LCM sample is not significantly
contaminated with nodule cortex cells (although some contami-
nation can be observed in case of probe set Mtr.37852.1.S1_at). In
addition, several genes that are reported to be specifically/most
highly expressed in the infection zone were examined. These
include for example MtN1, MtN6, MtAnn1, DNF1/DAS12, MtRR4,
MtN9/MtMMPL1 and MtEFD [31–37]. All these genes show
infection zone enriched expression in the LCM samples (Table 2,
Table S3), validating the results of the LCM analysis. As an
additional example, we verified the infection zone-specific
expression of the early nodulin MtENOD12 (Mtr.8924.1.S1_at)
by in situ hybridization. This showed that MtENOD12 is indeed
most highly expressed throughout the infection zone of the nodule
and not (or hardly) in the nodule meristem (Fig. 2a,b).
To our knowledge, there are currently no genes described that
are specifically/exclusively expressed in the nodule meristem of
Medicago. At the switch from meristem to infection zone, the
meristem-derived cells still enter the cell cycle, but instead of
dividing they undergo several rounds of endoreduplication
[38,39]. Therefore, we looked whether genes associated with
G2/M transition/cytokinesis are specifically enriched in the
meristem data set. Indeed, the cytokinesis-specific t-SNARE/
syntaxin Knolle (Mtr.41560.1.S1_at) and several cyclin and cyclin-
dependent kinase genes that are required for G2/M transition (B-
type cyclins: Mtr.31360.1.S1_at, Mtr.31859.1.S1_at; cyclin-de-
pendent kinases (CDK2): Mtr.50839.1.S1_at, Mtr.43543.1.S1_at)
show ‘‘meristem enriched’’ expression [39–41]. Among the genes
that appear nodule ‘‘meristem enriched’’ is also the WUSCHEL-
RELATED HOMEOBOX5 gene (MtWOX5; Mtr.33304.1.S1_at),
which is thought to also control stem cell activity in the root
meristem. Recently, it has been shown by promoter- b-
glucoronidase (GUS) reporter analyses that MtWOX5 is indeed
expressed in the nodule meristematic region, most specifically at
the tips of the vascular bundles [42]. These cells may be related to
meristem-organizing quiescent center cells, although the exact
organization of the nodule meristem and stem cell niche is not
known.
The Nod factor receptor LYK3 (Mtr.142.1.S1_s_at) also shows
meristem enriched expression in the LCM data. Previous in situ
hybridizations have shown that LYK3 is expressed in the proximal
site of the nodule meristem at the border with the infection zone,
where it may control the invasion of the meristematic cells by
infection threads [43]. To further confirm the predictive value of
the ‘‘meristem enriched’’ data set, the putative promoter region of
a ROP GTPase, (Mtr.35940.1.S1_at, Mtr.15539.1.S1_at), was
isolated and its expression determined by promoter-GUS analysis.
This confirmed the ‘‘meristem’’-specific expression of this gene in
Medicago nodules (Fig. 2c,d). These data indicate that the
meristematic region as captured can be clearly distinguished from
the infection zone.
Distal vs proximal infection zone. The infection zone can
be further divided into a distal and proximal zone based on the
developmental status of the symbiosomes in this part of the nodule.
In the distal part (,4 cell layers just below the meristem), after
infection threads have invaded the meristem-derived cells,
symbiosomes are formed (bacteria are released from the infection
threads) and symbiosomes divide. In the proximal ,4 cell layers
symbiosomes have stopped dividing and are terminally differen-
tiating by which they become much bigger and fill the growing
nodule cells. To identify genes potentially associated with these
different stages, we selected infection zone enriched genes that are
.2x enriched in the distal infection zone compared to the
proximal infection zone or vice-versa (Table S4, S5). Two genes
have been shown to be most highly expressed in the distal infection
zone. These are the early nodulin ENOD11 (Mtr.13473.1.S1_at)
and annexin MtANN1 (Mtr.14183.1.S1_at) [32,34]. Both genes
show distal infection zone enriched expression in the LCM array
data, confirming the specificity of the captured cells. Among the
genes that show a ‘‘proximal infection zone enriched’’ expression
(Table S5) is the nodule-specific IRE gene (Mtr.15644.1.S1_s_at).
This AGC-like kinase has been shown to be most highly expressed
in the proximal part of the nodule infection zone via promoter-
GUS analyses [44]. Additional genes that have been reported to
be expressed most highly in the proximal infection zone and which
show enrichment in the proximal infection zone LCM data,
include the phytocyanin-like ENOD20 (Mtr.17106.1.S1_at) [45]
and glycine-rich protein-encoding genes (GRPs;
Mtr.858.1.S1_s_at, Mtr.49309.1.S1_at) [46]. These data validate
the specificity of the LCM data to distinguish distal from proximal
cells in the infection zone of the nodule.
Infected vs uninfected cells. The fixation zone consists of
two cell types; infected and uninfected cells. To validate the
specificity of the infected versus uninfected LCM data we looked
for genes that are reported to be specifically expressed in either cell
type in Medicago. Recently, a basic helix–loop–helix transcription,
MtbHLH1, was shown to be expressed in Medicago nodules in the
uninfected cells and vascular bundles, where it is thought to
Figure 1. Laser capture microdissection of nodule cells. Panels represent 8 mM thick longitudinal sections of 3-week old Medicago nodules
before capture (a,d,g,j,m), after capture (b,e,h,k,n) and captured/isolated cells (c,f,i,l,o). Cells/tissues were isolated from the meristem (m; a–c), distal
infection zone (diz; d–f), proximal infection zone(piz; g–i), infected cells (ic; j–l) and uninfected cells (uic; m–o) from the fixation zone.
doi:10.1371/journal.pone.0064377.g001
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control vascular patterning and nutrient exchange [47]. In our
LCM data MtbHLH1 (Mtr.10993.1.S1_at) indeed shows specific
expression in the uninfected cells, confirming the reported
promoter-GUS data. To further validate the uninfected cell
LCM data we checked the expression pattern of MtENOD8.2
(Mtr.8511.1.S1_at), which shows anuninfected cell ‘‘specific’’
expression from the LCM data. ENOD8.2, like its close homolog
ENOD8.1, belongs to the GDSL family of lipase and esterase
proteins [48]. The putative promoter-region of MtENOD8.2 was
fused to b-glucoronidase and its expression pattern analyzed in
nodules. This analysis confirmed the uninfected cell ‘‘specific
expression’’ of MtENOD8.2 (Fig. 2e,f). Additionally, ENOD8.2 was
found to be expressed in the nodule parenchyma. Therefore, the
uninfected cell enriched data set presented here offers an
important insight into this essential nodule cell type (Table S7).
Several genes have been reported that show specific/highly
enriched expression in the infected cells of the fixation zone. These
include: Leghemoglobin genes [13], aquaporin Nodulin-26 [49],
Nodulin-25 [50], sulfate transporter SST1 [51], NCRs including
for example NCR001/NCR035 [11,52], and Calmodulin-like/CaML
genes [53]. All these genes indeed show enriched expression in the
LCM infected cells from the fixation zone (Table 2, Table S6)
confirming the specificity of the LCM data.
Cell/Tissue-specific Characteristics of Gene Expression in
Medicago Root Nodules
Next, we examined the nodule cell/tissue-specific transcrip-
tomes for characteristics that may be linked to the specific
processes that occur in these cell types, with a special focus on
symbiosome development and function.
‘‘Infection zone enriched’’. The infection zone data set
may contain numerous candidate genes that control the formation
and development of symbiosomes. The nodule-specific signal
peptidase subunit MtDNF1/DAS12, the putative metallo-pepti-
dase MtMMPL1 and the AP2/ERF transcription factor MtEFD
have indeed been shown to control infection and symbiosome
development in this part of the nodule. MtEFD has been shown to
be able to induce the expression of the A-type cytokinin response
regulator MtRR4, which is thought to negatively regulate cytokinin
signaling [36]. MtRR4 (Mtr.9656.1.S1_at) indeed shows specific
expression in the infection zone, with highest expression in the
proximal part (see transcriptional regulators below). Therefore,
downregulation of cytokinin signaling in the infection zone may be
required for proper differentiation of symbiosome and nodule
cells.
Terminal symbiosome differentiation is triggered by nodule-
specific cysteine-rich peptides (NCRs) that resemble antimicrobial
peptides. These NCRs contain a N-terminal signal peptide, which
is processed by a nodule specific signal peptidase complex
containing DNF1 that is active in the infection zone of the
nodule, by which these peptides are targeted to the symbiosomes
via a secretory pathway [11,37]. Most NCR peptides are
specifically induced in the infected cells of the infection zone, as
also determined by in situ hybridization or promoter-GUS analysis
[11,52]. However, several NCR encoding genes
(Mtr.35829.1.S1_at, Mtr.29559.1.S1_at, Mtr.37119.1.S1_at) are
specifically enriched in the infection zone, of which most tend to
be higher expressed in the proximal part of the infection zone
where terminal differentiation is observed (see also ‘‘proximal
enriched’’ below). These NCRs may be key candidates that initiate
the bacterial differentiation process.
‘‘Distal infection zone enriched’’. To identify ‘‘distal
infection zone enriched’’ genes we selected infection zone enriched
genes that are .2x enriched in the distal infection zone compared
to the proximal infection zone (Table S4). Among these genes are
ENOD11 (Mtr.13473.1.S1_at), ERN1 (Mtr.7556.1.S1_at), ERN2
(Mtr.43947.1.S1_at) and MtN2 (Mtr.3197.1.S1_at) [16,34,53,54].
It has been shown that the AP2/ERF transcription factors ERN1
and ERN2 function in the Nod factor signaling pathway and bind
to a conserved motif GCAGGCC (NF-box) in the promoter region
of ENOD11 where they act as transcriptional activators [53].
MtERN1 has been shown to be required for infection thread
initiation and maintenance of infection thread growth in the
epidermis [55]. Therefore, it can be hypothesized that ERN1
similarly controls infection events in the distal infection zone of the
nodule through the activation of specific genes. It is known that the
rhizobial nod genes involved in Nod factor production are still
expressed by rhizobia inside infection threads in the distal infection
zone of the nodule [56,57], where also the Nod factor receptors
are expressed [43] and that they are switched off as soon as the
bacteria are released into the cells [58]. This suggests that Nod
factor (NF) perception and signaling occur in these cells. To
investigate whether this is also reflected in the LCM expression
data, we compared the induction of genes 24 hours after NF
treatment in the root (reported by [25]) with the genes specifically
enriched in the apical part of nodule. This showed that ,20% (10
genes) of the ‘‘distal infection zone specific’’ genes are also induced
24 hours after NF treatment in plantlet roots (Table S8), whereas
only 1,5% (13) of the meristem specific genes or 4% (3) proximal
infection zone specific genes are induced by Nod factor treatment
there. This supports the hypothesis that NF signaling occurs at the
transition from the meristem to the distal infection zone. However,
overall, ,10% of the 283 NF-induced genes show specific
expression in the apical part of the nodule, which suggests that
many of the 24 h NF-induced genes are specifically induced in
root tissues.
Figure 2. LCM data validation. (a,b) In situ localization of MtENOD12 (antisense probe) in the infection zone of longitudinal sections of 14-day-old
Medicago nodules, representing brightfield (a; signal appears as black dots) and epipolarization images (b). (c,d) Promoter-GUS analysis of Medicago
ROP GTPase (Mtr.35940.1.S1_at, Mtr.15539.1.S1_at), showing b-glucoronidase (GUS) activity in the nodule meristem. (e,f) Promoter-GUS analysis of
MtENOD8.2, showing b-glucoronidase activity in the non-infected cells of the nodule as well as in the nodule parenchyma.
doi:10.1371/journal.pone.0064377.g002
Table 1. Number of genes showing cell/tissue specific or enriched expression.
Meristem Distal infection zone Proximal infection zone Total infection zone Infected cells Uninfected cells
895 53 70 299 1909 2072
Total: 4999 genes
doi:10.1371/journal.pone.0064377.t001
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An interesting gene that shows ‘‘specific’’ expression in the distal
infection zone is the Medicago ortholog (Mtr.26489.1.S1_at) of a
recently identified pectate lyase (LjNPL) in Lotus japonicus. LjNPL
was shown to control infection thread formation revealing that the
plant actively contributes to plant cell wall degradation to facilitate
rhizobial infection [59]. Therefore, MtNPL may also be involved
in infection thread formation in the nodule and/or the formation
of unwalled infection droplets to allow symbiosome formation.
The putative MtNPL promoter region does not contain a
conserved NF-box, indicating that different/additional transcrip-
tion factors control the induction of this gene, such as the putative
transcription factor NIN which was shown to bind to the LjNPL
promoter [59].
Another component that is implicated in rhizobial infection is
the ARP2/3 complex which controls actin polymerization.
Mutations in the SCAR/WAVE complex, involved in the
activation of the ARP2/3 complex, block infection by rhizobia
[60]. Among the distal infection zone enriched genes is a subunit
of the ARP2/3 complex (Mtr.37170.1.S1_at). Interestingly, an
ortholog of this subunit was recently shown in Lotus to control
rhizobial infection [61]. Therefore, control of the actin cytoskel-
eton likely also plays a key role in the nodule to control infection
thread formation and possibly symbiosome formation [62].
One of the most specifically expressed genes in the distal
infection zone encodes a putative protease inhibitor,
Mtr.35511.1.S1_at. This gene is also highly induced in arbuscular
mycorrhizal (AM) roots, specifically in cells containing arbuscules
[63]. It has recently become clear that rhizobia recruited the
signaling pathway, including lipo-chitooligosaccharide signal
molecules and receptor, from the ancient AM symbiosis to
establish an intracellular symbiotic interface [64,65]. Therefore, it
is tempting to speculate that this protease inhibitor is involved in
the intracellular accommodation of both symbionts. However,
despite the shared signaling pathway there is overall only a limited
overlap in genes that show enriched expression in mycorrhized
roots and symbiosome containing nodule cells (Table S13).
‘‘Proximal infection zone enriched’’. Among the genes
that show a ‘‘proximal infection zone enriched’’ expression (Table
S5) is the nodule-specific AGC kinase gene IRE
(Mtr.15644.1.S1_s_at) [44]. AGC kinases are key regulators of
cell growth and MtIRE could potentially play an important role in
symbiosome and/or nodule cell enlargement, possibly through the
regulation of vesicle trafficking or cytoskeletal organization [66]. A
list of (receptor-like) kinases enriched in the different cells or tissues
is represented in Table S9.
Another striking (distal and) proximal infection zone specific
gene is a close homolog of the CLAVATA1-related AtBAM3
receptor-like kinase (Mtr.4752.1.S1_at). In Arabidopsis BAM
kinases regulate meristem function at shoot and flower meristems
through complex interactions with CLAVATA signaling [67].
CLE peptides have been identified as ligands for such receptor-like
kinases and another CLAVATA1 homolog, in Medicago called
SUNN, has been shown to control nodule number in the process
of autoregulation of nodule numbers [68]. It is therefore tempting
to speculate that MtBAM3 plays a role in the perception of CLE
peptides (such as the recently identified MtCLE12 and MtCLE13)
in the nodule to control the balance between cell proliferation and
differentiation.
As mentioned above, terminal symbiosome differentiation is
triggered by nodule-specific NCR peptides [11]. Several NCR
peptides appear most highly induced in the proximal part of the
infection zone coinciding with the induction of symbiosome
differentiation. These include: Mtr.4538.1.S1_at,
Mtr.48527.1.S1_at and Mtr.10836.1.S1_at. Most of these NCR
genes, including the infection zone-enriched NCRs
Mtr.35829.1.S1_at, Mtr.29559.1.S1_at, Mtr.37119.1.S1_at, al-
ready show enriched expression in the distal infection zone.
Therefore, these NCR’s may be key NCR peptides to initiate
symbiosome differentiation.
Several genes involved in cytokinin signaling show highest
expression in the proximal infection zone. These include a
histidine phosphotransfer encoding gene (Mtr.11120.1.S1_at),
two cytokinin-specific phosphoribohydrolase LOGs
(Mtr.39530.1.S1_at, Mtr.50458.1.S1_at) which activate cytokinins
[69], as well as two A-type RR genes (Mtr.9656.1.S1_at (MtRR4),
Mtr.17273.1.S1_s_at) and a cytokinin oxidase (Mtr.14413.1.S1_at)
that negatively regulate cytokinin signaling. Therefore, we
speculate that cytokinin signaling is tightly regulated in the
(proximal) infection zone of the nodule to control the proper
differentiation of nodule cells and symbiosomes.
‘‘Infected cell enriched’’. Among the genes that show
enrichment in the infected cells of the fixation zone is the essential
Nod factor signaling gene DMI1 (Mtr.19417.1.S1_at,
Mtr.124.1.S1_s_at), which encodes a putative cation channel that
is required to induce calcium-spiking upon Nod factor perception
in the epidermis [70,71]. DMI1 was also identified by Moreau and
co-workers [27] as a late expressed gene in their transcriptome
analyses. Furthermore, the interacting protein of DMI3, IPD3
(Mtr.3453.1.S1_s_at) is most highly expressed in the infected cells
of the fixation zone, as confirmed by promoter-reporter analyses
[72,73]. Also DMI3 was shown to be expressed throughout the
infection zone up to the fixation zone [74]. This indicates that
several components of the Nod factor signaling pathway are also
active at relatively late stages in the nodules, most likely to control
symbiosome development [73]. As the bacterial nod genes are not
active in these cells it suggests that additional mechanisms,
independent of Nod factor perception, are able to activate DMI3
in these cells.
A functional nitrogen-fixing symbiosis requires the efficient
transport of metabolites to, and from, the nitrogen-fixing
symbiosomes. The bacteroids require carbohydrates from the
plant, which are mainly supplied in the form of dicarboxylic acids,
especially malate [14]. In pea it has been shown that bacteroids
also need to be supplied by branched-chain amino acids [75]. How
these components are transported across the symbiosome mem-
brane, resembling transport to the apoplast [9], is currently not
known. Additional minerals that need to be supplied by the host
cells are for example zinc, iron, magnesium and sulfate. Most of
these components will need specific transporters on the symbio-
some membrane to be transported to the bacteroids, as
exemplified by the sulfate transporter SST1 (Mtr.37708.1.S1_at)
[51]. However, in most cases the transporters involved are not
known. Therefore, we searched for putative transporters that are
specifically enriched in the infected cells containing nitrogen-fixing
symbiosomes (based on Mapman and GO classification). These
‘‘infected cell enriched’’ transporters are summarized in Table
S10. Among the genes are putative candidates for the transport of
malate (Mtr.13956.1.S1_at), zinc (Mtr.41323.1.S1_at,
Mtr.32958.1.S1_at), nitrate (Mtr.40270.1.S1_at), potassium
(Mtr.9837.1.S1_at) and several aquaporin-like proteins potentially
transporting ammonium [76].
‘‘Meristem enriched’’. The nodule meristem was captured
to serve as one of the uninfected reference/control tissues for the
infected nodule cell types. However, in addition, the meristem
enriched transcriptome gives first insight into molecular players
that controls its organization.
Among the genes that appear nodule ‘‘meristem enriched’’ (Table
S2) are many genes that are associated with meristematic/dividing
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cells. These include the WUSCHEL-RELATED HOMEOBOX5 gene
(MtWOX5; Mtr.33304.1.S1_at), SCARECROW (MtSCR;
Mtr.39371.1.S1_at) and BABY BOOM gene (MtBBM;
Mtr.21627.1.S1_at) which are known to control stem cell activity in
the root meristem [77,78]. This supports the hypothesis that nodule
formation recruits a program involved in lateral root formation
[79,80]. Furthermore, the array data indicate an important role for
auxin signaling in the control and maintenance of a functional nodule
meristem. Several auxin signaling related genes show a ‘‘meristem
specific’’ expression in the nodule. These include for example: AUX/
IAA’s (Mtr.43054.1.S1_at, Mtr.38407.1.S1_at, Mtr.43345.1.S1_at,
Mtr.10432.1.S1_at, Mtr.48811.1.S1_at, Mtr.13714.1.S1_at,
Mtr.41219.1.S1_at, Mtr.33279.1.S1_at), ARF’s (Mtr.26217.1.S1_at,
Mtr.35827.1.S1_at, Mtr.11167.1.S1_at, Mtr.39377.1.S1_at,
Mtr.24462.1.S1_at, Mtr.44217.1.S1_at), TIR1-like F-box
(Mtr.37555.1.S1_at), PIN auxin efflux carriers (Mtr.45124.1.S1_at,
Mtr.38716.1.S1_at) and auxin responsive genes such as GH3-like
(Mtr.6663.1.S1_at, Mtr.40094.1.S1_at, Mtr.41237.1.S1_at) and
SAUR-like genes (Mtr.20120.1.S1_at, Mtr.19927.1.S1_x_at). The
importance of auxin in the nodule meristem was also suggested from
the activation of auxin responsive promoters in the nodule meristem
[81]. Furthermore, auxin signaling has been linked to the control of
nodule numbers in the process of autoregulation. One of the genes that
is highly expressed in the nodule meristem is the Medicago ortholog
(Mtr.43054.1.S1_at) of IAA14/SLR (SOLITAIRY ROOT), which has
been shown to control lateral root formation [82,83]. In Arabidopsis, a
stabilizing mutation in IAA14 blocks lateral root formation by
inhibiting the auxin response factors ARF7 and ARF19 [82,84].
Interestingly, several mutants, such as the pea cochleata and Medicago
noot mutant, have been identified where the nodule meristem switches
to a root meristem and roots emerge from the nodules [79,80].
Therefore, the upregulation of IAA14 expression in the nodule
meristem may play a role in inhibiting the switch to a lateral root
meristem. However, given the number of auxin-related signaling
genes, auxin signaling in the nodule meristem is likely to be a complex
process involving various feedback loops.
‘‘Uninfected cell enriched’’. As an additional reference
cell-type uninfected cells from the fixation zone were captured.
Although uninfected cells are thought to play an essential role in
metabolite transport in functional nodules. The uninfected cell
enriched data set presented here offers a first insight into this
essential nodule cell type (Table S7).
Carbon derived from photosynthesis is transported mainly as
sucrose via the phloem, which is thought to be cleaved/converted
in the uninfected nodule cells into malate to be transferred to the
infected cells [14]. In support of this, several genes involved in
sucrose cleavage and transport are found specifically/enriched in
the uninfected cells. These include: putative SWEET/MtN3-like
sucrose transporters (Mtr.42041.1.S1_at, Mtr.43349.1.S1_at,
Mtr.8585.1.S1_at, Mtr.41025.1.S1_at) [85], sucrose/H+ co-trans-
porters (Mtr.21349.1.S1_s_at, Mtr.12339.1.S1_at), sucrose syn-
thases (Mtr.2239.1.S1_at, Mtr.43674.1.S1_at,
Mtr.22018.1.S1_s_at), and a sucrose-cleavage protein
(Mtr.43417.1.S1_at).
Uninfected cells in legumes such as Medicago are further
thought to play a role in the transport/export of fixed nitrogen in
the form of amides, of which asparagine is considered to be the
major exported nitrogenous compound [14]. Several genes
involved in asparagine synthesis, such as ASPARAGINE SYNTHE-
TASE, have been found to be highly expressed in uninfected cells
in alfalfa, in addition to their expression in infected cells [86]. The
LCM array data show that also in Medicago asparagine synthase
(Mtr.8498.1.S1_at; Mtr.8499.1.S1_at; Mtr.32211.1.S1_at;
Mtr.7084.1.S1_at) genes are strongly enriched in the uninfected
cells. This supports a major physiological role for the uninfected
cells in the export of fixed nitrogen in the form of asparagine in
Medicago. Interestingly, the uninfected cell ‘‘specific’’ MtbHLH1
transcription factor (Mtr.10993.1.S1_at) was shown to be required
for expression of the uninfected cell enriched asparagine synthase
(Mtr.8499.1.S1_at), suggesting that it might bind to its promoter
[47]. Furthermore, several putative amino-acid transporters,
potentially involved in the transport of amino-acids to or from
the infected cells, appear to be enriched in the uninfected cells of
the nodule (Table S11).
Analysis of the ‘‘uninfected cell enriched’’ gene set indicated a
relatively high number of genes, compared to the infected nodule
cells, that can be associated with biotic stress or defense responses
against pathogenic microbes according to Mapman classification
[87] (Figure S1a,b). This supports the hypothesis that suppression
of defense responses in the infected cells is essential to allow the
accommodation of the rhizobia. Among these genes are several
key enzymes involved in phenylpropanoid metabolism (Figure
S1e,f) and in jasmonic acid biosynthesis (Figure S1c,d), including
several lipoxygenase (LOX) genes (Mtr.30415.1.S1_s_at,
Mtr.37265.1.S1_at, Mtr.46864.1.S1_at, Mtr.8462.1.S1_at). LOX
gene expression correlates with jasmonate levels and LOX protein
and transcripts have been detected in the uninfected cells of
Phaseolus vulgaris and pea nodules [88,89]. Jasmonates have
emerged as important signals in both beneficial and pathogenic
plant-microbe interactions and show a complex interplay with
Nod factor signaling and the plant hormones salicylic acid and
ethylene [90–93]. Therefore, jasmonates may play a key role in the
development of uninfected cells by controlling defense responses or
by affecting the formation of secondary signals required for
symbiosis through their effect on secondary metabolism or
signaling [93].
Transcriptional Regulators in Nodule Cell Types
To identify potential key transcriptional regulators in the
different cell types we looked for cell-type enriched/specific
transcription factors. These are summarized in Table S12.
73 genes appear to be specifically enriched in the meristem of
the nodule, representing various TF families. As mentioned earlier
TFs related to auxin signaling (AUX/IAA and ARFs) are enriched
in the nodule meristem, as well as various homeobox domain
containing TFs, which may be key regulators of nodule meristem
organization.
Among the 7 TFs enriched in the distal infection zone are the
above described AP2/ERF transcription factors ERN1 and ERN2
as well as an additional uncharacterized AP2/ERF TF
(Mtr.17511.1.s1_at). Also a gene (Mtr.1584.1.S1_at) encoding a
CCAAT-domain binding transcription factor of the HAP2 type
appears to be specifically expressed in the distal infection zone,
similar to the MtHAP2-1 TF controlling symbiosome formation
[93]. In situ hybridization by Combier and colleagues [94]
suggested that MtHAP2-1 (Mtr.43750.1.s1_at) is most strongly
expressed in the meristem of the nodule, however in the LCM
array data it appears to be most enriched in the distal infection
zone. This might be due to the control of MtHAP2-1 expression by
miRNAs that could leave transcript that can be detected via
GeneChip hybridizations.
Most striking among the 5 proximal infection zone enriched
TFs are two A-type cytokinin response factors (Mtr.9656.1.s1_at,
Mtr.17273.1.s1_s_at), including MtRR4 which was shown to be
regulated by the transcription factor EFD [36]. Both genes are
already induced in the distal infection zone, but show the strongest
enrichment in the proximal infection zone. As discussed above,
this suggests that down-regulation of cytokinin signaling in the
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(proximal) infection zone is important to allow differentiation and
the proper development of the symbiosomes.
Among the 54 putative TFs that are specifically enriched in the
infected cells of the fixation zone, there may be key regulators of
the infected cell-specific transporter genes (Table S9) and of the
characteristic metabolism that facilitates rhizobial nitrogen-
fixation. Strikingly, almost 3 times more TFs (143) appear to be
specifically enriched in the uninfected cells of the fixation zone,
including notably 16 AP2/ERF TFs, 14 Homeobox domain TFs
and 7 SCARECROW-like GRAS-type TFs. This relatively high
number of uninfected cell enriched transcriptional regulators
highlights the important role of this cell-type in nodule function-
ing.
Conclusion
Here we present a comprehensive gene expression map of an
indeterminate Medicago nodule, covering the nodule meristem,
(distal and proximal) infection zone as well as infected and
uninfected cells from the fixation zone. Our LCM array data fit
very well with published gene expression profiles and several cell/
tissue specific genes were experimentally verified, indicating that
the data may be used as digital ‘‘in situ’’. Many nodule-specifc
processes that are essential for a successful nitrogen fixing
symbiosis, such as symbiosome formation, differentiation and
maintenance, nodule meristem development, nodule cell differen-
tiation (infected vs uninfected cells), and metabolite transport
processes in the nodule are still far from understood. Therefore,
the cell- and tissue-specific data sets presented here offer a valuable
resource for further functional studies.
Materials and Methods
Plant Growth and Infection
Medicago truncatula accession Jemalong A17 was used. Nodula-
tion was done according to Limpens et al., 2004 using a 2 ml
suspension (OD600 0.1) of Sinorhizobium meliloti strain Sm2011 per
plant in (agra)perlite saturated with nitrate-free Fa¨hraeus medium.
Three weeks after inoculation nodules were harvested for LCM.
Agrobacterium rhizogenes mediated root transformation were per-
formed as described by Limpens et al. [95], using A. rhizogenes
strain MSU440.
Laser Capture Microdissection
Three week-old nodules were fixed in Farmer’s fixative (3:1
ethanol:acetic acid), after 30 min. vacuum, at 4uC overnight.
Fixed nodules were further dehydrated through an ethanol series:
75%, 85%, 100% (4x) for 15 min. each at room temperature (RT).
At the first 100% ethanol step eosin B was added to facilitate the
recognition of the nodule meristem during the sectioning steps.
Nodules were subsequently infiltrated with xylene: ethanol 1:3,
1:1, 3:1 and finally 100% xylene (3x); 30 min at RT each. Next,
the nodules were infiltrated with liquid filtered paraffin (Paraplast)
at 60uC for 2 days including 4 changes of paraffin. After
solidification, 8 mm sections were cut on a RJ2035 microtome
(Leica Microsystems, Rijswijk, The Netherlands). Only those
consecutive sections that contained a well-developed nodule
meristem (based on eosin B staining observed using a binocular)
were subsequently deparaffinized using 100% xylene 265 min.
each, air dried and immediately used for laser capture using a
PixCell II LCM system (Arcturus). For each biological replicate, 8
consecutive sections containing ,50 cells/section were collected
and used for RNA isolation. Sections that showed a distorted
nodule ontology were discarded. Three biological replicates were
collected per cell/tissue-type.
RNA Extraction and GeneChip Hybridizations
The Qiagen RNeasy Micro kit was used for RNA isolation
according to manufacturer’s instructions, with one modification:
for the LCM captured cells 50 ng poly-Inosine was added to
350 ml RLT buffer as carrier RNA. On-column DNAse treatment
was performed according to the manufacturer’s recommendation.
The amount and quality of the RNA in the paraffin embedded
nodules was verified before laser capture using agarose gel
electrophoresis and using a ND-1000 spectrophotometer (Nano-
Drop Technologies). The amount and quality of the RNA isolated
from the LCM samples was too low to be accurately determined
using an Agilent 2100 Bioanalyzer due to the added poly-I.
RNA was processed for use on Affymetrix (Santa Clara, CA,
USA) Medicago GeneChips. Samples were amplified according to
the first amplification cycle of the Affymetrix Two-cycle Target
Labeling kit user manual. Briefly, total RNA containing spiked-in
poly-A+ RNA controls was used in a reverse transcription reaction
(Two-cycle Target Labeling kit; Affymetrix, Santa Clara, CA,
USA) to generate first-strand cDNA. After second-strand synthesis,
double-stranded cDNA was used in a 16 h in vitro transcription
(IVT) reaction to generate aRNA (Two-cycle Target Labeling kit).
The generated aRNA samples were than processed according to
the Affymetrix GeneChip 39 IVT Express kit user manual. Briefly,
100 ng of aRNA was used in a reverse transcription reaction
(GeneChip 39 IVT Express Kit; Affymetrix, Santa Clara, CA,
USA) to generate first-strand cDNA. Double-stranded cDNA
obtained by second-strand synthesis was then used in a 16 h IVT
reaction to generate aRNA (GeneChip 39 IVT Express Kit). Size
distribution of in vitro transcribed aRNA and fragmented aRNA,
respectively, was assessed via an Agilent 2100 Bioanalyzer (Agilent,
Bo¨blingen, Germany), using an RNA 6000 Nano Assay. 30 mg to
40 mg of fragmented aRNA was added to a 250-ml (final volume)
hybridization cocktail containing hybridization controls. 200 ml of
the mixture was hybridized on GeneChips for 16 h at 45uC.
Standard post-hybridization wash and double-stain protocols
(FS450_0001; GeneChip HWS kit; Affymetrix, Santa Clara, CA,
USA) were used on an Affymetrix GeneChip Fluidics Station 450.
GeneChips were scanned on an Affymetrix GeneChip scanner
3000 7G.
Packages from the Bioconductor project [96] were used to
analyze the array data according to Liu et al. [97]. Only the 5 most
39located probe sets on the GeneChip were used to account for
observed 39bias. To identify genes enriched in a particular LCM
sample, genes were first selected that show enriched expression, at
least 2-fold higher (p,0.01, q ,0,1 ), compared to the average of
all other LCM samples. An intensity-based moderated T-statistic
(IBMT) [98] was used to calculate p-values and q-values corrected
for multiple testing [99]. The obtained (relative) expression values
were further analyzed using Microsoft Office Excel 2007 software.
Genes that showed $2x enrichment compared to all other samples
were selected as ‘‘cell-type enriched’’ genes. Expression data were
further compared to expression data obtained from the Medicago
Gene Expression Atlas (http://mtgea.noble.org/v2/; [22]) and
data (24 h NF treatment) published by Czaja et al. [25]. Venn
diagrams were created using Venny software (http://bioinfogp.
cnb.csic.es/tools/venny/index.html). MapMan software (version
3.5.1) (http://mapman.gabipd.org/web/guest/mapman) was used
to analyze gene profiles using the Mt_AFFY_Mt3.1_0510
mapping.
The complete dataset is available from the Gene Expression
Omnibus, under accession GSE43354.
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Promoter-GUS Analyses
Putative promoter regions were PCR amplified from Medicago
genomic DNA using Phusion high fidelity Taq polymerase (New
England Biolabs) and directionally cloned into pENTR-D-TOPO
(Invitrogen). The following primers were used: MtLYK3p-F
CACCTGAATCAAGAAGAGAGAGAGAAAGAG, MtLYK3p-
R AGCCAAGTACATGAGATTGGATAA; MtROP2p-F
CACCTAGCTTTATCACACACAAATGTCCC, MtROP2p –
R ATTGTATAAATGGAACTAAGGTTTTGTTG; MtE-
NOD8.2p-F CACCTCAATAGGGCATGTTACAAAAAGTG,
MtENOD8.2p-R GAATTTCATGAAGCACAAAGGAAC.
After sequence analysis, the corresponding pENTR clones were
used to recombine the promoters into pKGWFS2-RR [100],
creating a promoter:GUS-GFP reporter fusion. Transgenic roots
were obtained via A. rhizogenes mediated root transformation.
Histochemical GUS staining was performed according to [100] up
to 4 hours in 0.1 M phosphate buffer pH7.0 containing, 3%
sucrose, 5 mM EDTA, 0.5 mM K4Fe(CN)6, 0.5 mM K3Fe(CN)6
and 1 mM X-gluc (dissolved in DMFO) at 37uC. Subsequently,
the GUS stained nodules were fixed using 5% glutaraldehyde (in
0.1 M phosphate buffer) and embedded in technovit 7100
(Heraeus-Kulzer) according to the manufacturers protocol.
10 mm sections were cut using a Reichert-Jung 2035 microtome,
counterstained with 0.1% ruthenium red, and analyzed using a
Leica DM5500B microscope equipped with a Leica DFC425C
camera (Leica microsystems, Germany).
In situ Hybridization
In situ hybridization of Medicago nodules were performed as
described by Limpens et al. [43], based on the protocol by van de
Wiel et al. [101]. A 220 bp ENOD12 cDNA fragment was
amplified using primers: ENOD12-iF (AGGCATCCTCCAGCA-
GAAGA), ENOD12-iR (ATAGCACGATTTTACACTCA-
TACCTCATA), and cloned into the pCRII-Blunt TOPO vector
(Invitrogen). T7 and Sp6 primers were used to synthesize
radioactively label (sense and antisense) RNA probes after
digesting the plasmids with NotI (sense) or SpeI (antisense). For
hybridization 26106 cpm 35S (sense and antisense) labeled probe
was used.
Supporting Information
Figure S1 Schematic representation of genes specifically en-
riched (filled squares; selected $2 enriched) in infected (a,c,e) and
uninfected (b,d,f) cells from the fixation zone according to
Mapman v.3.5.1 classification (Mt_AFFY_Mt3.1_0510 mapping).
(a,b) Genes potentially associated with biotic stress. (c,d) Genes
associated with jasmonic acid synthesis. (e,f) Genes involved in
phenylpropanoid metabolism.
(TIF)
Table S1 Gene expression ‘‘enrichment’’ in a particular LCM
sample compared to the average of all other samples, based on the
five most 39 located Medicago truncatula probe sets on the
Medicago GeneChips. Column A: Medicago GeneChip Id;
Column B: gene name; Column C: Gene Annotation; Column
D: Mean expression value (log2) in all LCM samples; Column E–
V: fold enrichment for each LCM cell/tissue including p and q
(corrected for multiple testing) statistics and average signal
intensity (A) from three biological replicates; Column E–
G = Meristem, H–J = distal infection zone. K–M = Proximal
infection zone, N–P = distal+proximal infection zone, Q–S = In-
fected cells from the fixation zone, T–V = Uninfected cells from
the fixation zone. Column W–Z: log2 expression values from the
Medicago Gene Expression Atlas (http://mtgea.noble.org/v2/;),
representing Column W = root, X = 4 day old nodules, Y = 10 day
old nodules, Z = 14 day-old nodules. Column AA: Gene Ontology
(GO) Biological function ID, Column AB: Biological function GO
term, Column AC: Molecular Function GO ID, Column AD:
Molecular function GO term, Column AE: prediced gene function
based on EuKaryotic Orthologous Groups.
(XLSB)
Table S2 Genes showing enriched expression specifically in the
nodule meristem.
(XLS)
Table S3 Genes showing enriched expression in the infection
zone of the nodule.
(XLS)
Table S4 Genes showing enriched expression specifically in the
distal infection zone.
(XLS)
Table S5 Genes showing enriched expression specifically in the
proximal infection zone.
(XLS)
Table S6 Genes showing enriched expression specifically in the
infected cells of the fixation.
(XLS)
Table S7 Genes showing enriched expression specifically in the
uninfected cells of the fixation zone.
(XLS)
Table S8 Selected genes showing 2 fold upregulation upon 24 h
Nod factor treatment, based on Czaja et al., 2012 [25].
(XLS)
Table S9 Putative (receptor) protein kinase genes showing
enriched expression specifically in the nodule meristem (sheet 1),
distal infection zone (sheet 2), proximal infection zone (sheet 3),
total infection zone (sheet 4), infected cells from the fixation zone
(sheet 5) and uninfected cells (sheet 6).
(XLS)
Table S10 Genes encoding putative transporters enriched in the
infected cells of the fixation zone.
(XLS)
Table S11 Genes encoding putative transporters enriched in the
uninfected cells of the fixation zone.
(XLS)
Table S12 Transcription factor genes showing enriched expres-
sion specifically in the meristem (sheet 1), distal infection zone
(sheet 2), proximal infection zone (sheet 3), total infection zone
(sheet 4), infected cells from the fixation zone (sheet 5) and
uninfected cells (sheet 6).
(XLS)
Table S13 Genes showing enriched expression in mycorrhized
roots, according to the Medicago Gene Expression Atlas (http://
mtgea.noble.org/v2/).
(XLS)
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